Position in IRWD
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,082,031
+$1,051,540 QoQ
Shares Held
308,271
+3307.1% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 32.42958306165679.ToString("F0")%
Shared 0.ToString("F0")%
None 67.57041693834321.ToString("F0")%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026LSV ASSET MANAGEMENT holds $422,940,937 across 17 Drug Manufacturers - Specialty & Generic names. IRWD ranks #14 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
398,665 | $236,400,371 | |
| 2 | VTRS |
Viatris Inc
|
7,890,441 | $106,599,857 | |
| 3 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
651,714 | $12,767,077 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
517,100 | $11,686,460 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
345,200 | $11,415,764 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
373,734 | $11,391,412 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
165,300 | $9,142,743 | |
| 8 | EBS |
Emergent BioSolutions Inc.
|
896,700 | $7,442,610 |
All Filings in IRWD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,082,031 | 308,271 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $30,491 | 9,048 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $1,980,144 | 2,750,200 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,876,767 | 3,997,801 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $18,081,049 | 4,081,501 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $20,812,596 | 5,051,601 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $39,586,186 | 6,071,501 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $53,575,218 | 6,151,001 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $77,587,235 | 6,782,101 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $68,991,332 | 7,164,209 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $81,612,087 | 7,670,309 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $79,717,498 | 7,577,709 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $98,208,058 | 7,926,397 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $81,991,319 | 7,914,220 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $86,234,680 | 7,479,157 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $93,184,211 | 7,407,330 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $87,536,353 | 7,507,406 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $102,027,684 | 7,812,227 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $56,167,601 | 4,364,227 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $10,889,308 | 973,999 | Shares | Sole | 2021-04-30 | |
| No filing history on record for this holder in this stock. | ||||||